contractor articles (631)
Active Articles:
A53008: Billing and Coding: Intraocular BevacizumabA53024: Billing and Coding: JW and JZ Modifier Billing Guidelines
A53026: Billing and Coding: Bariatric Surgery Coverage
A53032: Self-Administered Drug Exclusion List:
A53296: Billing and Coding: Wound Care & Debridement – Provided by a Therapist, Physician, NPP or as Incident-to Services
A53322: Billing and Coding: Fracture Care
A53339: Billing and Coding: Therapy Students and Aides
A53356: Sterilization
A53972: Billing and Coding: Spinal Fusion Services: Documentation Requirements
A54061: Billing and Coding: Arthroscopic Lavage and Arthroscopic Debridement for Osteoarthritic Knees
A54386: Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update
A54422: Billing and Coding: MolDX: FDA-Approved EGFR Tests
A54547: Response to Comments: MolDX: Molecular Diagnostic Tests (MDT)
A54589: Response to Comments: MolDX: Prolaris Prostate Cancer Genomic Assay, L36340
A54594: Response to Comments: Special Histochemical Stains and Immunohistochemical Stains, L36346
A54630: Response to Comments: MolDX: Decipher Prostate Cancer Classifier Assay
A54644: Response to Comments: Immune Globulin Intravenous (IVIg)
A54710: Response to Comments: Treatment of Varicose Veins of Lower Extremities
A54893: Response to Comments: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia
A54895: Response to Comments: MolDX: MGMT Promoter Methylation Analysis
A54927: Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
A54929: Billing and Coding: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers – Coding and Billing
A54969: Billing and Coding: Nerve Conduction Studies and Electromyography
A54978: Response to Comments: MolDX: Biomarkers in Cardiovascular Risk Assessment
A54980: Response to Comments: Spinal Cord Stimulators for Chronic Pain
A54990: Response to Comments: Nerve Conduction Studies and Electromyography
A54998: Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing Comment Period Ending 05/02/2014.
A55001: Billing and Coding: Urine Drug Testing
A55028: Billing and Coding: Lab: Bladder/Urothelial Tumor Markers
A55033: Response to Comments: MolDX-CDD: Genomic Health™ Oncotype DX® Prostate Cancer Assay
A55044: Billing and Coding: Patients Supplied Donated or Free-of-Charge Drug
A55048: Response to Comments: MolDX: NRAS Genetic Testing
A55053: Response to Comments: Treatment of Males with Low Testosterone
A55072: Response to Comments: Total Hip Arthroplasty
A55079: Response to Comments: Total Knee Arthroplasty
A55154: Response to Comments: Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs)
A55239: Billing and Coding: Implantable Infusion Pumps for Chronic Pain
A55294: Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
A55361: Response to Comments: Serum Magnesium
A55372: Response to Comments: Vitamin D Assay Testing
A55383: Response to Comments: Botulinum Toxin Types A and B
A55457: Response to Comments: Bladder/Urothelial Tumor Markers
A55470: Response to Comments: MolDX- CDD: ProMark Risk Score
A55472: Response to Comments: Trigger Point Injections
A55489: Response to Comments: Injections - Tendon, Ligament, Ganglion Cyst, Tunnel Syndromes and Morton's Neuroma
A55491: Response to Comments: Polysomnography and Other Sleep Studies
A55527: Response to Comments: GlycoMark Testing for Glycemic Control
A55530: Billing and Coding: Peripheral Nerve Stimulation
A55553: Response to Comments: Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography
A55555: Response to Comments: Diagnostic and Therapeutic Colonoscopy
A55595: Billing and Coding: MolDX: BCR-ABL
A55597: Billing and Coding: MolDX: PIK3CA Gene Tests
A55624: Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Testing in Cancer
A55657: Response to Comments: MolDX DecisionDX Uveal Melanoma
A55661: Response to Comments: MolDX: Xpresys Lung
A55684: Response to Comments: Plastic Surgery
A55688: Response to Comments: Cataract Surgery in Adults
A55710: Lymphedema Decongestive Treatment
A55719: Sipuleucel-T (Provenge®) - Coverage Criteria for Prostate Cancer – Clarification
A55754: Billing and Coding: Home PT/INR Monitoring (G0249) Billing and Coding
A55778: Response to Comments: MolDX: Prometheus IBD sgi Diagnostic Policy
A55793: Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression Test
A55902: Response to Comments: Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder
A55936: Response to Comments: Chest X-Ray Policy
A55984: Response to Comments: Respiratory Care (Respiratory Therapy)
A56017: Response to Comments: Lumbar MRI
A56025: Billing and Coding: Topical HBO and Physician Related Service Billing and Coding Guidelines
A56034: Billing and Coding: Nerve Blockade for Treatment of Chronic Pain and Neuropathy
A56041: Response to Comments: Peripheral Nerve Stimulation
A56061: Response to Comments: MRI and CT Scans of Head and Neck
A56071: Billing and Coding: In Vitro Chemosensitivity & Chemoresistance Assays
A56076: Response to Comments: In Vitro Chemosensitivity & Chemoresistance Assays
A56103: Billing and Coding: MolDX: Microsatellite Instability-High (MSI-H) and Mismatch Repair Deficient (dMMR) Biomarker for Patients with Unresectable or Metastatic Solid Tumors
A56152: Billing and Coding: Pulmonary Rehabilitation Services
A56211: Response to Comments: MolDX: Cystatin C Measurement
A56230: Response to Comments: MolDX: DecisionDx-Melanoma
A56240: Response to Comments: Frequency of Hemodialysis
A56253: Response to Comments: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor
A56256: Response to Comments: MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
A56340: Billing and Coding: Implantable Automatic Defibrillators
A56356: Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test
A56375: Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test
A56381: Response to Comments: Helicobacter Pylori Infection Testing
A56411: Response to Comments: MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer
A56446: Response to Comments: MolDX: MDS FISH
A56514: Billing and Coding: Mohs Micrographic Surgery
A57124: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
A57161: Billing and Coding: Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs)
A57183: Billing and Coding: Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography
A57185: Billing and Coding: Botulinum Toxin Types A and B Policy
A57189: Billing and Coding: Serum Magnesium
A57195: Billing and Coding: Cataract Surgery in Adults
A57204: Billing and Coding: MRI and CT Scans of the Head and Neck
A57206: Billing and Coding: Lumbar MRI
A57224: Billing and Coding: Respiratory Care
A57326: Billing and Coding: Electrocardiograms
A57331: Billing and Coding: MolDX: Repeat Germline Testing
A57342: Billing and Coding: Diagnostic and Therapeutic Colonoscopy
A57363: Billing and Coding: MolDX: Breast Cancer Assay: Prosigna®
A57372: Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
A57384: Billing and Coding: MolDX: Pharmacogenomics Testing
A57419: Billing and Coding: MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
A57421: Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
A57423: Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
A57432: Billing and Coding: MolDX: MGMT Promoter Methylation Analysis
A57441: Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
A57486: Billing and Coding: MolDX: NRAS Genetic Testing
A57515: Billing and Coding: ProMark® Risk Score
A57516: Billing and Coding: MolDX: Prometheus® IBD sgi Diagnostic® Policy
A57523: Billing and Coding: MolDX: Immunohistochemistry (IHC) Indications for Breast Pathology
A57526: Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)
A57607: Billing and Coding: MolDX: EndoPredict® Breast Cancer Gene Expression Test
A57611: Billing and Coding: Lab: Special Histochemical Stains and Immunohistochemical Stains
A57619: Billing and Coding: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
A57643: Billing and Coding: Lab: Cystatin C Measurement
A57692: Billing and Coding: Transcranial Magnetic Stimulation (TMS)
A57706: Billing and Coding: Treatment of Varicose Veins of the Lower Extremities
A57718: Billing and Coding: Vitamin D Assay Testing
A57791: Billing and Coding: Spinal Cord Stimulators for Chronic Pain
A57818: Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
A57842: Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268)
A57848: Billing and Coding: Tomosynthesis-Guided Breast Biopsy
A57891: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
A57894: Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
A57901: Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors
A57904: Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors
A57907: Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS)
A57938: Response to Comments: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
A57954: Billing and Coding: Routine Foot Care
A58052: Billing and Coding: MolDX: Pigmented Lesion Assay
A58072: Response to Comments: MolDX Pigmented Lesion Assay
A58095: Billing and Coding: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
A58133: Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM)
A58168: Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection
A58176: Response to Comments: MolDX: Repeat Germline Testing
A58181: Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A58223: Billing and Coding: Computed Tomography Cerebral Perfusion Analysis (CTP)
A58227: Billing and Coding: Transurethral Waterjet Ablation of the Prostate
A58237: Response to Comments: MolDX: Pharmacogenomics Testing
A58271: Response to Comments: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
A58340: Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)
A58403: Billing and Coding: Facet Joint Interventions for Pain Management
A58454: Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers
A58505: Response to Comments: MolDX: Blood Product Molecular Antigen Typing
A58507: Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing
A58509: Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
A58520: Response to Comments: Computed Tomography Cerebral Perfusion Analysis (CTP)
A58522: Response to Comments: Transurethral Waterjet Ablation of the Prostate
A58534: Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
A58565: Billing and Coding: Wound and Ulcer Care
A58596: Response to Comments: Colon Capsule Endoscopy (CCE)
A58634: Response to Comments: Non-Invasive Fractional Flow Reserve (FFR) for Stable Ischemic Heart Disease
A58639: Response to Comments: Facet Joint Interventions for Pain Management
A58669: Response to Comments: MolDX: Breast Cancer Index® (BCI) Gene Expression Test
A58673: MolDX: Algorithm definition as a component of a laboratory test
A58679: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A58718: Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
A58748: Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A58778: Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection
A58781: Response to Comments: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
A58783: Response to Comments: MolDX: EndoPredict Breast Cancer Gene Expression Test
A58855: Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS)
A58865: Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
A58903: Response to Comments: Wound and Ulcer Care
A58944: Response to Comments: Colon Capsule Endoscopy (CCE)
A58953: Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer
A58966: Response to Comments: Platelet Rich Plasma Injections for Non-Wound Injections
A58973: Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
A58993: Billing and Coding: Epidural Steroid Injections for Pain Management
A58996: Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers
A59017: Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
A59079: Response to Comments: Epidural Steroid Procedures Injections for Pain Management
A59130: Response to Comments: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A59134: Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing
A59142: Response to Comments: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
A59151: Response to Comments: Nerve Blockade for Treatment of Chronic Pain and Neuropathy
A59175: Billing and Coding: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
A59211: Response to Comments: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
A59244: Billing and Coding: Sacroiliac Joint Injections and Procedures
A59278: Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
A59325: Response to Comments: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s and Non-Hodgkin’s Lymphoma with B-Cell or T-Cell Origin
A59333: Response to Comments: Sacroiliac Joint Injections and Procedures
A59353: Response to Comments: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
A59386: Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
A59413: Response to Comments: Cataract Surgery In Adults
A59419: Response to Comments: Magnetic Resonance Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's Disease
A59440: Response to Comments: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
A59443: Response to Comments: Transcranial Magnetic Stimulation (TMS)
A59452: Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A59459: Response to Comments: Urine Drug Testing
A59466: Billing and Coding: Intraosseous Basivertebral Nerve Ablation
A59505: Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
A59509: Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
A59513: Billing and Coding: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
A59521: Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
A59523: Response to Comments: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
A59531: Response to Comments: Respiratory Care
A59541: Response to Comments: Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
A59596: Response to Comments: Transurethral Waterjet Ablation of the Prostate
A59598: Response to Comments: Intraosseous Basivertebral Nerve Ablation
A59611: Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)
A59624: Billing and Coding: Cervical Fusion
A59641: Billing and Coding: MolDX: Proteomics Testing
A59651: Response to Comments: Trigger Point Injections (TPI)
A59657: Billing and Coding: Artificial Hearts and Percutaneous Endovascular Cardiac Assist Procedures and Devices
A59685: MolDX: Defining panel services in MolDX
A59743: MolDX: Clarification of Order Requirements for Laboratory and Molecular Diagnostic services
A59747: Response to Comments: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
A59752: Billing and Coding: Cryoneurolysis Instructions
A59793: Response to Comments: Facet Joint Interventions for Pain Management
A59796: Response to Comments: Cervical Fusion
A59830: Response to Comments: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
A59854: Response to Comments: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
A59896: Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS)
Retired Articles:
A52484: Injectable Bulking Agents for the Treatment of Fecal IncontinenceA52547: Chemotherapy Administration
A52564: Changes in Noridian’s List of Drugs that are Usually Self Administered - R1
A52656: Hyperthermia Therapy for Cancer Treatment
A52663: Percutaneous Endovascular Cardiac Assist Procedures and Devices
A52789: Coverage and Non-Coverage of CPT Category III Codes
A52798: Pegfilgrastim (Neulasta) J2505
A52966: Billing and Coding: Artificial Hearts and Percutaneous Endovascular Cardiac Assist Procedures and Devices
A53031: Self-Administered Drug Exclusion List
A53138: Medical Nutrition Therapy - R2
A53144: Sclerosing of Varicose Veins
A53182: Testopel™ Coverage
A53287: Billing and Coding: High Compression Bandage System Clarification
A53828: HemoDialysis Frequency
A53956: High Resolution Anoscopy
A54068: Billing and Coding: Outpatient Cardiac Rehabilitation
A54072: Billing and Coding: Treatment with Yttrium-90 Microspheres
A54129: Ocular Photodynamic Therapy (OPT) with Verteporfin
A54355: MolDX: Afirma™ Assay by Veracyte Billing and Coding Guidelines
A54356: Billing and Coding: MolDX: Afirma™ Assay by Veracyte
A54363: MolDX: AlloMap Billing and Coding Guidelines
A54375: MolDX: Avise PG Assay Billing and Coding Guidelines
A54376: Billing and Coding: MolDX: Avise PG Assay
A54385: MolDX: bioTheranostics Cancer TYPE ID® Billing and Coding Guidelines
A54428: MolDX: Corus® CAD Test Billing and Coding Guidelines
A54437: Billing and Coding: MolDX: HERmark® Assay by Monogram
A54479: MolDX: Oncotype DX® Breast Cancer Assay Billing and Coding Guidelines
A54483: MolDX: Oncotype DX® Colon Cancer Coding and Billing Guidelines
A54494: Billing and Coding: MolDx: ResponseDX Tissue of Origin®
A54497: MolDX: FDA-Approved KRAS Tests
A54502: MolDX: Vectra™ DA Billing and Coding Guidelines
A54503: Billing and Coding: MolDX: Vectra™ DA
A54536: Intraocular Bevacizumab Coding/Billing Guidelines
A54542: Therapeutic Apheresis for Familial Hypercholesterolemia
A54666: Billing and Coding: Positron Emission Tomography Scans Coverage
A55085: Billing and Coding: MolDX: CHD7 Gene Analysis
A55104: Billing and Coding: Posterior Tibial Nerve Stimulation Coverage
A55177: Billing and Coding: MolDX: CYP2B6 Test
A55179: Billing and Coding: MolDX: CYP2C9 and/or VKORC1 Gene Testing for Warfarin Response
A55181: Billing and Coding: MolDX: ENG and ACVRL1 Gene Tests
A55183: Billing and Coding: MolDX: FANCC Genetic Testing
A55185: MolDX: FDA Approved ALK Companion Diagnostic Tests Billing and Coding Guidelines
A55212: Incident To Clarification for OPPS and CAH Outpatient
A55253: Billing and Coding: MolDX: HBB Gene Tests
A55255: Billing and Coding: MolDX: HEXA Gene Analysis
A55274: Billing and Coding: MolDX: Know error®
A55277: Billing and Coding: MolDX: L1CAM Gene Sequencing
A55283: Billing and Coding: MolDX: MCOLN1 Genetic Testing
A55285: Billing and Coding: MolDX: MECP2 Genetic Testing
A55292: Billing and Coding: MolDX: myPap™
A55482: Billing and Coding: MolDX: UGT1A1 Gene Analysis
A55593: Billing and Coding: MolDX: OncoCee™
A55607: Additional Information Required for Coverage and Pricing for Category III CPT® Codes
A55612: Billing and Coding: MolDX: IKBKAP Genetic Testing
A55627: Billing and Coding: MolDX: SMPD1 Genetic Testing
A55881: Billing and Coding: MolDX: ThermoFisher Oncomine Dx Target Test For Non-Small Cell Lung Cancer
A56371: Billing and Coding: MolDX: Genomic Health™ Oncotype DX® Prostate Cancer Assay
A56706: Billing and Coding: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs)
A57202: Billing and Coding: Lumbar Epidural Injections
A57336: Billing and Coding: 4Kscore® Assay
A57338: Billing and Coding: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels
A57352: Billing and Coding: MolDX: APC and MUTYH Gene Testing
A57354: Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing
A57415: Billing and Coding: MolDX: Corus® CAD Assay
A57459: Billing and Coding: Treatment of Ulcers & Symptomatic Hyperkeratoses
A57509: Billing and Coding: MolDX: Prolaris™ Prostate Cancer Genomic Assay
A57514: Billing and Coding: MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease
A57645: Billing and Coding: MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Very Low and Low Risk Disease
A58141: Billing and Coding: Mometasone Furoate Sinus Implant (Sinuva, Propel family of Implants)
A58384: Billing and Coding: Remote Imaging of the Retina to Screen for Retinal Diseases
A59165: Response to Comments: Lumbar Epidural Injections